On May 5, 2023, BiomX Inc. closed the transaction. the company has issued 24,632,243 shares of common stock at a price of $0.245 per share, for gross proceeds of $6,000,000 in its second tranche closing.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 USD | +4.17% | +20.69% | +25.00% |
Apr. 18 | Biomx Inc. Appoints Susan Blum to Its Board of Directors and Member and Chair of the Audit Committee of the Board | CI |
Apr. 03 | Transcript : BiomX Inc., Q4 2023 Earnings Call, Apr 03, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.00% | 19.33M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PHGE Stock
- News BiomX Inc.
- BiomX Inc. announced that it has received $7.496224 million in funding from Cystic Fibrosis Foundation, OrbiMed Advisors LLC